Vanguard Group Inc Cardiovascular Systems Inc Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.31 - $19.86 $1.46 Million - $2.17 Million	109,406 Added 3.85%	2,954,461 $58.7 Million
Q4 2022 Feb 10, 2023	BUY	$12.74 - $15.12 $1.25 Million - $1.48 Million	98,056 Added 3.57%	2,845,055 $38.7 Million
Q3 2022 Nov 14, 2022	BUY	$12.93 - $17.17 $777,519 - $1.03 Million	60,133 Added 2.24%	2,746,999 $38.1 Million
Q2 2022 Aug 12, 2022	BUY	$13.53 - $23.34 $1.31 Million - $2.26 Million	97,034 Added 3.75%	2,686,866 $38.6 Million
Q1 2022 May 13, 2022	SELL	$16.14 - $22.6 $1.78 Million - $2.5 Million	-110,546 Reduced 4.09%	2,589,832 $58.5 Million
Q4 2021 Feb 14, 2022	BUY	$18.64 - $36.77 $353,731 - $697,784	18,977 Added 0.71%	2,700,378 $50.7 Million
Q3 2021 Nov 12, 2021	BUY	$32.83 - $43.0 $691,038 - $905,107	21,049 Added 0.79%	2,681,401 $88 Million
Q2 2021 Aug 13, 2021	BUY	$34.41 - $44.03 $91.5 Million - $117 Million	2,660,352 New	2,660,352 $113 Million

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.